Journal of Business Ethics 117 (1):45-65 (2013)
Abstract |
In recent years, the biopharmaceutical industry has seen an increase in the development of so-called orphan drugs for the treatment of rare and neglected diseases. This increase has been spurred on by legislation in the United States, Europe, and elsewhere designed to promote orphan drug development. In this article, we examine the drivers of corporate social responsibility (CSR) activities in orphan drug markets and the extent to which biopharmaceutical firms engage in these activities with a strategic orientation. The unique context of orphan drugs constitutes a research opportunity to test the applicability of existing theoretical perspectives on CSR and strategic CSR. Using Schwartz and Carroll’s (Bus Ethics Q, 13(4):503–530, 2003) three-domain approach to CSR and the literature on strategic CSR as a theoretical background, we employ a combination of semi-structured interviews and a quantitative website content analysis to study practices of biopharmaceutical firms in the United States and European Union. Our findings show that both US- and EU-based companies engaged in orphan drugs development perceive their involvement as a responsible business activity beyond the economic dimension of CSR. However, for the majority of these companies their CSR activities do not qualify as strategic according to the criteria established in the literature. We also find significant differences between larger and smaller firms in their use of CSR. Based on these findings, we make several suggestions regarding orphan drug legislation and other measures that might help firms exploit strategic CSR benefits
|
Keywords | Biopharmaceutical industry Corporate social responsibility (CSR) European Union (EU) Orphan drugs Rare diseases Strategic CSR United States (US) |
Categories | (categorize this paper) |
ISBN(s) | |
DOI | 10.1007/s10551-012-1496-y |
Options |
![]() ![]() ![]() ![]() |
Download options
References found in this work BETA
Corporate Social Responsibility Evolution of a Definitional Construct.Archie B. Carroll - 1999 - Business and Society 38 (3):268-295.
The Corporate Social Performance and Corporate Financial Performance Debate.John F. Mahon - 1997 - Business and Society 36 (1):5-31.
The Corporate Social Performance and Corporate Financial Performance Debate Twenty-Five Years of Incomparable Research.Jennifer J. Griffin & John F. Mahon - 1997 - Business and Society 36 (1):5-31.
Corporate Social Responsibility: A Three-Domain Approach.Mark S. Schwartz & Archie B. Carroll - 2003 - Business Ethics Quarterly 13 (4):503-530.
Corporate Social Responsibility (CSR): Models and Theories in Stakeholder Dialogue.Linda O’Riordan & Jenny Fairbrass - 2008 - Journal of Business Ethics 83 (4):745-758.
View all 24 references / Add more references
Citations of this work BETA
A Corporate Social Responsibility Analysis of Payday Lending.Mark S. Schwartz & Chris Robinson - 2018 - Business and Society Review 123 (3):387-413.
Shared Decision Making Bei Seltenen ErkrankungenShared Decision Making in Rare Diseases.Franziska Krause - 2019 - Ethik in der Medizin 31 (2):131-141.
Similar books and articles
Industry Social Standings: A Social Audit of the Beer Industry.James Weber & Jennifer J. Griffin - 2005 - Proceedings of the International Association for Business and Society 16:190-195.
Expressions of Corporate Social Responsibility in U.K. Firms.Diana C. Robertson & Nigel Nicholson - 1996 - Journal of Business Ethics 15 (10):1095 - 1106.
Environmental Integrity and Corporate Responsibility.Richard H. Guerrette - 1986 - Journal of Business Ethics 5 (5):409 - 415.
Ethical Issues in Outsourcing: The Case of Contract Medical Research and the Global Pharmaceutical Industry. [REVIEW]Henry Adobor - 2012 - Journal of Business Ethics 105 (2):239-255.
Strategic Corporate Social Responsibility in Controversial Industry Sectors: The Social Value of Harm Minimisation. [REVIEW]Margaret Lindorff, Elizabeth Prior Jonson & Linda McGuire - 2012 - Journal of Business Ethics 110 (4):457-467.
Putting Corporate Responsibility Into Practice: Examining the Gap Between Strategic Plans and Operational Actions.Johanna Kujala, Paula Merikari & Jenni Enroth - 2007 - Proceedings of the International Association for Business and Society 18:192-196.
Social Responsibility, Social Capital, and Corporate Competitive Advantage in Transitional China.Junwei Shi, Haiyan Fu & Lijun Hu - 2007 - International Corporate Responsibility Series 3:377-394.
Industry, Innovation and Social Values.Harvey E. Bale - 2005 - Science and Engineering Ethics 11 (1):31-40.
Using Industry Analysis to Develop Boundary Conditions for Responding to the Social Environment.Andrea K. Young - 2007 - Proceedings of the International Association for Business and Society 18:289-293.
Is There Room at the Bottom for CSR? Corporate Social Responsibility and Nanotechnology in the UK.Chris Groves, Lori Frater, Robert Lee & Elen Stokes - 2011 - Journal of Business Ethics 101 (4):525-552.
Corporate Social Responsibility: A Strategic Advantage or a Strategic Necessity? [REVIEW]Joyce Falkenberg & Petter Brunsæl - 2011 - Journal of Business Ethics 99 (S1):9-16.
Introducing Ethics and Corporate Social Responsibility at Undergraduate Level in the United Arab Emirates: An Experiential Exercise on Website Communication. [REVIEW]Valerie Priscilla Goby & Catherine Nickerson - 2012 - Journal of Business Ethics 107 (2):103-109.
Analytics
Added to PP index
2012-09-27
Total views
38 ( #298,645 of 2,505,175 )
Recent downloads (6 months)
2 ( #277,206 of 2,505,175 )
2012-09-27
Total views
38 ( #298,645 of 2,505,175 )
Recent downloads (6 months)
2 ( #277,206 of 2,505,175 )
How can I increase my downloads?
Downloads